Publicaciones en colaboración con investigadores/as de Medical Research Council (5)

2016

  1. Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals

    Medicine (United States), Vol. 95, Núm. 41

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2008

  1. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up

    Journal of Infectious Diseases, Vol. 197, Núm. 8, pp. 1145-1155

  2. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART Study

    Journal of Infectious Diseases, Vol. 197, Núm. 8, pp. 1133-1144

  3. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial

    Annals of Internal Medicine, Vol. 149, Núm. 5, pp. 289-299